Muutke küpsiste eelistusi

E-raamat: Recent Advances in Dialysis Therapy in Japan

Edited by , Edited by , Series edited by , Edited by , Edited by , Edited by
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 326,04 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Recent Advances in Dialysis Therapy in JapanSuurem pilt
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

The number of dialysis patients, and their ages, continues to increase globally. This creates major issues such as rising medical costs in an aging population, how to best manage end-of-life care, and how to train the various practitioners involved in dialysis care. After the US and China, Japan occupies 3rd place with regard to the number of dialysis patients and is also widely regarded as a world leader in dialysis. This book contains selected articles organized into 4 chapters - that discuss recent advances in dialysis therapy in Japan. Chapter 1 presents insights into causes, risk factors, disease associations, and possible implications for management of dialysis patients. Chapter 2 examines recent progress in hemodialysis treatment, and chapter 3 focuses on developments in peritoneal dialysis. The final chapter concentrates on recent advances in apheresis and current trends in practice, among other topics. This book is aimed at nephrologists, physicians, urologists, nurses, clinical engineers, pharmacists, and nutritionists. It is a significant contribution to furthering the progress of dialysis therapy worldwide.
Preface ix
H. Nakamoto
Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis 1(4)
T. Kobayashi
T. Noguchi
K. Saito
F. Shirasaki
H. Kita
M. Nagata
H. Okada
H. Nakamoto
Chapter 1 New Opinions on Dialysis Therapy
Current Perspectives on Sudden Cardiac Death in Hemodialysis Patients
5(8)
N. Joki
M. Tokumoto
N. Takahashi
M. Nishimura
Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients
13(9)
H. Io
Y. Suzuki
Asymptomatic Cerebrovascular Disease in Dialysis Patients
22(5)
T. Naganuma
Y. Takemoto
Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease
27(10)
K. Tsuruya
H. Yoshida
Targets and Therapeutics for Glycemic Control in Diabetes Patients on Hemodialysis
37(7)
N. Maruyama
M. Abe
Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels
44(8)
M. M. Ohya
T. Yashiro
K. Sonou
K. Okuda
Tatsuta
T. Mima
Y. Tone
S. Negi
Y. Saika
T. Shigematsu
Importance of Physiological Erythropoiesis in the Treatment of Chronic Kidney Disease-Associated Anemia
52(6)
T. Kuragano
T. Nakanishi
Magnesium in Hemodialysis Patients: A New Understanding of the Old Problem
58(6)
Y. T. Sakaguchi
Hamano
Y. Isaka
Does Combined Therapy with Peritoneal Dialysis and Hemodialysis Improve Prognosis?
64(7)
Y. Maruyama
Pathogenesis and Management of Vascular Calcification in Patients with End-Stage Renal Disease
71(7)
T. Ogawa
K. Nitta
Chapter 2 Hemodialysis (Complications, Nursing Care, Home Care)
Total Renal Care Approach for Patients with End-Stage Renal Disease
78(5)
Y. S. Kamijo
Fujimoto
Y. Ishibashi
Ferritin: Diversity and Management of Ferritin Measurement Methods
83(5)
D. M. Kamei
M. Mineshima
N. Tsukada
N. Miwa
Hanafusa
K. Tsuchiya
Current Status and Treatment Strategies of Hemodialysis-Associated Pruritus
88(8)
N. T. Takahashi
Yoshizawa
S. Tsuchiya
Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients
96(5)
T. Higuchi
Management of Physical Frailty in Patients Requiring Hemodialysis Therapy
101(9)
R. Matsuzawa
B. Roshanravan
Advances and Developments in Vascular Access in Japan
110(4)
S. Hirotani
Intermittent Infusion Hemodiafiltration: The Principle and Its Clinical Application
114(5)
K. M. Eguchi
D. Mineshima
Kamei
K. Tsuchiya
Treatment of Hepatitis C Virus Infection in Dialysis Patients
119(4)
K. Kikuchi
Chapter 3 Peritoneal Dialysis, Home Dialysis
Current Status of Peritoneal Dialysis in Japan
123(6)
Y. Ito
M. Tawada
S. M. Tine
Mizuno
Y. Suzuki
T. Katsuno
Current State of Peritoneal Dialysis in Children
129(6)
H. Hataya
Effect of Combined Peritoneal Dialysis and Hemodialysis on Health-Related Quality of Life
135(6)
Y. Watanabe
H. Okada
Peritoneal Dialysis in Elderly Patients
141(7)
K. Sakai
H. Nihei
Blood Pressure Control in Peritoneal Dialysis Patients
148(7)
M. Ryuzaki
The Role of Non-Tuberculous Mycobacteria in Peritoneal Dialysis-Related Infections: A Literature Review
155(7)
N. Washida
H. Itoh
Translational Research of Peritoneal Dialysis Solution with Dissolved Molecular Hydrogen
162(9)
M. Nakayama
K. Watanabe
Y. Hayashi
H. Terawaki
W.-J. Zhu
S. Kabayama
S. Ito
A Perspective on the Current Status of Home Hemodialysis
171(7)
H. Kawanishi
Home Hemodialysis: Benefits, Risks, and Barriers
178(6)
K. Tomori
H. Okada
Intensive Hemodialysis: Effects of Treatment Time and Frequency on Time-Averaged Concentrations of Solutes
184(4)
M. Mineshima
Chapter 4 AKI, Apheresis, and Cross-Sections
Apheresis for Kidney Disease
188(6)
K. Furuichi
T. Wada
Our Approaches to Selective Plasma Exchange
194(6)
T. H. Ogawa
Y. Yoshino
Y. Sasaki
T. Kanayama
Y. Sano
K. Kogure
Kanozawa
H. Hasegawa
Changes in Treatment with Granulocyte and Monocyte Adsorptive Apheresis from the Past to Future in Patients with Inflammatory Bowel Disease
200(9)
S. A. Kato
K. Ishibashi
K. Sugiura
T. Kani
H. Ogawa
K. Hasegawa
Yakabi
Current Practices in Acute Blood Purification Therapy in Japan and Topics for Further Study
209(6)
T. H. Sadahiro
T. Yuzawa
M. Kimura
T. Oguchi
S. Morito
Mizushima
Y. Hirose
Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among Critically III Patients
215(8)
C. K. Yamashita
D. Moriyama
Y. Hasegawa
N. Hara
T. Kuriyama
J. Nakamura
H. Shibata
Komura
O. Nishida
Current Trend of Pediatric Renal Replacement Therapy in Japan
223(6)
M. Hattori
Dysnatremia in Renal Failure
229(8)
T. M. Shimizu
H. Terao
T. Hara
T. Iwashita
K. Ogawa
Kanozawa
H. Hasegawa
Methods We Currently Use for Home Hemodialysis Management
237(6)
Y. T. Sasaki
Y. Ogawa
K. Kanayama
T. Tokui
K. Morita
Y. Yasuda
H. Okada
T. Hara
Shimizu
H. Hasegawa
Protein Energy Wasting and Sarcopenia in Dialysis Patients
243(7)
H. Y. Hara
M. Nakamura
T. Hatano
T. Iwashita
T. Shimizu
K. Ogawa
Kanozawa
H. Hasegawa
Author Index 250(2)
Subject Index 252
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97833180629842e.html
Märksõnad: